“The Use of Double Test Biomarkers to Predict Fetal Nuchal Translucency Thickness in the Diagnosis of Trisomy 21: A Compromise Between Sensitivity and Specificity”. 2018. Central Asian Journal of Medical Sciences 4 (3): 230-37. https://doi.org/10.24079/cajms.2018.09.009.